« FDA Approvals - Are Two FDA Approvals in One Week a Positive Sign?Don't | Main | FDA announces new safety recommendations for high-dose simvastatin The U.S. »

Regeneca, Inc. Announces Submittal of Response to FDA Warning LetterIRVINE,


Regeneca, Inc. Announces Submittal of Response to FDA Warning Letter
IRVINE, Calif. -- Regeneca, Inc. has submitted a Response Letter to the FDA Warning Letter received on May 27, 2011. The letter outlines the actions taken by Regeneca to ensure the compliance of its products and marketing materials related to RegenErect, Regeneca's male enhancement product.
 

©2006 FDA-News.com. All rights reserved.